Company profile
ImmuONE Innovative Solutions For Inhalation Safety
https://immuone.com/wp-content/uploads/2022/06/heartbeat-1.webm INNOVATIVE SOLUTIONS FOR INHALATION SAFETY ImmuONE specialises in human alveolar macrophage responses and epithelial cell culture platforms Explore our services IN VITRO INNOVATION SERVICES FOR EMPOWERED DECISION MAKING ImmuONE provides innovative in vitro products and testing services for inhalation safety assessment using state-of-the-art techniques. Our specialist team of in vitro scientists can work with []
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNzkzNDM3N2FkaXF6a2N4 | Paper/PDF filed
Published 06 Oct 2024 06:08
Company registered at Companies House
1 Jun 2020 to 30 Nov 2020
no public description
1 Jan 2020 to 30 Jun 2021
"We breathe over 23 000 times a day. Along with the air in each breath we take, there are other substances present, which are largely dependent on the environment we live in. The chemicals we breathe in depend on lifestyle choices (smoking, cosmetics), occupation (industrial chemicals, particulates), location (exhaust fumes, pollen) and health conditions ...
